Immunovant Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Immunovant stock has a consensus rating of "Buy" and an average price target of $45.76. The average 1-year stock price forecast is 36.11% higher than the current stock price, while the lowest is $24 (-28.61%) and the highest is $66 (+96.31%).

Price Target: $45.76 (+36.11%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$24	$45.76	$45	$66
Change	-28.61%	+36.11%	+33.85%	+96.31%

Analyst Ratings

The average analyst rating for Immunovant stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	11	11	11	11	11	11
Buy	2	2	2	2	2	2
Hold	4	4	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	17	18	18	18	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $66	Buy	Maintains	$66	+96.31%	May 29, 2026
Brian Cheng J.P. Morgan	J.P. Morgan	Buy Maintains $35 → $47	Buy	Maintains	$35 → $47	+39.80%	May 26, 2026
Yatin Suneja Guggenheim	Guggenheim	Buy Maintains $44 → $62	Buy	Maintains	$44 → $62	+84.41%	May 26, 2026
Douglas Tsao H.C. Wainwright	H.C. Wainwright	Buy Reiterates $40	Buy	Reiterates	$40	+18.98%	May 26, 2026
Alex Thompson CFA Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $49	Buy	Maintains	$49	+45.75%	May 25, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

60.92M

EPS This Year

-2.44

from -2.47

EPS Next Year

-2.44

from -2.44

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	-	-	-	-	-	-
Operating Income	-156.03M	-208.28M	-270.21M	-438.15M	-532.90M	-558.77M
Net Income	-156.73M	-210.96M	-259.34M	-413.84M	-505.61M	-557.07M
EPS	-	-	-	-	-2.47	-2.44
Free Cash Flow	-47.88M	-107.82M	-124.15M	-227.82M	-234.28M	-506.70M
No. Analysts	-	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2027	2028	2029
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2028	2029
High	-
Avg	-
Low	-

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	-2.44
Low	-

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-